Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.38B |
| 2 |
Microsoft
MSFT
|
+$1.13B |
| 3 |
Amazon
AMZN
|
+$756M |
| 4 |
Tesla
TSLA
|
+$466M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$199M |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$191M |
| 3 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$62.8M |
| 4 |
KL
Kirkland Lake Gold Ltd Ordinary
KL
|
+$43.9M |
| 5 |
ATH
Athene Holding Ltd. Class A Common Shares
ATH
|
+$42.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.22% |
| 2 | Healthcare | 14.23% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Communication Services | 9.53% |
| 5 | Industrials | 8.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CCXI
1801
DELISTED
ChemoCentryx, Inc.
CCXI
| $2.91M | ﹤0.01% |
115,900
+8,200
| +8% | +$230K |
|
|
BRKL
1802
DELISTED
Brookline Bancorp
BRKL
| $2.9M | ﹤0.01% |
183,600
+11,400
| +7% | +$192K |
|
|
CNR
1803
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $2.9M | ﹤0.01% |
119,400
+9,100
| +8% | +$181K |
|
1804
Monarch Casino & Resort
MCRI
$2.18B
| $2.9M | ﹤0.01% |
33,211
+2,600
| +8% | +$194K |
|
1805
Sturm, Ruger & Co
RGR
$602M
| $2.9M | ﹤0.01% |
41,600
+2,900
| +7% | +$200K |
|
1806
Pilgrim's Pride
PPC
$6.55B
| $2.89M | ﹤0.01% |
115,200
+7,800
| +7% | +$202K |
|
1807
Seaboard Corp
SEB
$4.01B
| $2.89M | ﹤0.01% |
687
+47
| +7% | +$182K |
|
1808
National Bank Holdings
NBHC
$1.94B
| $2.89M | ﹤0.01% |
71,700
+3,700
| +5% | +$164K |
|
1809
Revolution Medicines
RVMD
$43.5B
| $2.89M | ﹤0.01% |
113,200
+7,700
| +7% | +$168K |
|
1810
Standex International
SXI
$4.04B
| $2.89M | ﹤0.01% |
28,900
+2,000
| +7% | +$210K |
|
1811
DNOW Inc
DNOW
$2.96B
| $2.88M | ﹤0.01% |
261,400
+19,000
| +8% | +$184K |
|
1812
Arcus Biosciences
RCUS
$3.67B
| $2.88M | ﹤0.01% |
91,296
+4,800
| +6% | +$161K |
|
1813
TriCo Bancshares
TCBK
$1.86B
| $2.88M | ﹤0.01% |
71,900
+6,400
| +10% | +$278K |
|
|
NXGN
1814
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $2.87M | ﹤0.01% |
137,400
+11,900
| +9% | +$228K |
|
1815
Fulgent Genetics
FLGT
$515M
| $2.87M | ﹤0.01% |
45,900
+3,700
| +9% | +$244K |
|
1816
Innoviva
INVA
$1.5B
| $2.86M | ﹤0.01% |
147,900
+10,200
| +7% | +$182K |
|
1817
Malibu Boats
MBUU
$573M
| $2.86M | ﹤0.01% |
49,300
+3,500
| +8% | +$226K |
|
1818
e.l.f. Beauty
ELF
$5.45B
| $2.86M | ﹤0.01% |
110,700
+8,000
| +8% | +$218K |
|
1819
Archrock
AROC
$5.87B
| $2.86M | ﹤0.01% |
309,600
+20,300
| +7% | +$174K |
|
|
RWT
1820
Redwood Trust
RWT
$602M
| $2.85M | ﹤0.01% |
271,100
+21,400
| +9% | +$244K |
|
1821
Columbus McKinnon
CMCO
$544M
| $2.85M | ﹤0.01% |
67,311
+4,700
| +8% | +$212K |
|
1822
Phreesia
PHR
$760M
| $2.85M | ﹤0.01% |
108,200
+8,000
| +8% | +$245K |
|
1823
Uranium Energy
UEC
$5.55B
| $2.85M | ﹤0.01% |
621,100
+108,000
| +21% | +$397K |
|
|
UMH
1824
UMH Properties
UMH
$1.41B
| $2.85M | ﹤0.01% |
115,900
+11,500
| +11% | +$276K |
|
1825
Codexis
CDXS
$178M
| $2.85M | ﹤0.01% |
138,000
+10,300
| +8% | +$213K |
|
Similar funds
Swiss National Bank's Q1 2022 Portfolio in Review
As of Q1 2022, Swiss National Bank held 2,722 positions worth $177B, up 6.8% from $166B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Swiss National Bank deployed $20.2B of net new capital in Q1 2022, opening 3 new positions and adding to 2,642 existing holdings. Its largest new stake was Constellation Energy: 1,411,783 shares worth $79.4M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Exelon, an estimated $41.2M trimmed.
- Swiss National Bank's largest Q1 2022 buy was Constellation Energy: 1,411,783 shares worth $79.4M.
- Swiss National Bank added most to Apple in Q1 2022, an estimated $1.38B increase.
- Swiss National Bank's biggest Q1 2022 reduction was Exelon, cutting an estimated $41.2M.
- Swiss National Bank fully exited Xilinx Inc in Q1 2022, selling an estimated $199M.
- Swiss National Bank's ten largest holdings make up 28% of its $177B portfolio in Q1 2022.
- Swiss National Bank opened 3 new positions and closed 31 in Q1 2022.
- Swiss National Bank's portfolio value rose 6.8% quarter-over-quarter to $177B.
Based on Swiss National Bank's 13F filing for Q1 2022, filed 9 May 2022.